STELLIAM INVESTMENT MANAGEMENT, LP - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 27 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
STELLIAM INVESTMENT MANAGEMENT, LP ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$16,265,000
-46.1%
11,500,000
-57.0%
0.54%
-46.5%
Q3 2016$30,177,000
+7.0%
26,750,000
+4.9%
1.01%
+3.5%
Q2 2016$28,209,000
+79.0%
25,500,000
+75.9%
0.98%
+100.0%
Q1 2016$15,760,00014,500,0000.49%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Birch Grove Capital LP 7,424,000$7,748,0004.66%
Bruce & Co., Inc. 5,500,000$5,500,0001.26%
IRON Financial LLC 1,025,000$1,066,0000.94%
TENOR CAPITAL MANAGEMENT Co., L.P. 9,291,000$9,812,0000.90%
Sonora Investment Management, LLC 1,430,000$1,495,566,0000.28%
CSS LLC/IL 3,305,000$3,445,0000.17%
FMR LLC 5,100,000$5,247,0000.00%
Allianz Asset Management GmbH 700,000$728,0000.00%
JPMORGAN CHASE & CO 4,365,000$4,605,0000.00%
North Star Investment Management Corp. 1,000$1,0000.00%
View complete list of AMAG PHARMACEUTICALS INC shareholders